Jasper Therapeutics Inc (JSPR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.18M
Last updated: Nov 17, 2026 at 11:05 AM ET
Jasper Therapeutics Inc (JSPR) Earnings: Report Dates and Results
Jasper Therapeutics (JSPR) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Jasper Therapeutics reported EPS of -$33.93, below the -$5.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
JSPR has an expected report date of Mar 29, 2027.
Earnings History
Of the 21 quarters below that had an estimate, JSPR beat 12, missed 8 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 563.99% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$33.93 | -$5.11 | N/A | -563.99% | Miss | N/A | 1 | 1 up, 0 down | Nov 16, 2026 |
| Jun 30, 2026 | -$0.24 | -$0.37 | -$0.55 - -$0.33 | +35.14% | Beat | N/A | 2 | 1 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.38 | -$0.54 | -$0.54 - -$0.54 | +29.63% | Beat | N/A | 1 | 1 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$0.54 | -$0.82 | -$1.20 - -$0.52 | +33.82% | Beat | N/A | 5 | 0 up, 1 down | Mar 30, 2026 |
| Sep 30, 2025 | -$1.13 | -$1.21 | -$1.92 - -$0.75 | +6.61% | Beat | N/A | 6 | 1 up, 0 down | Nov 10, 2025 |
| Jun 30, 2025 | -$1.74 | -$1.33 | -$1.48 - -$0.76 | -30.83% | Miss | N/A | 9 | 2 up, 1 down | Aug 13, 2025 |
| Mar 31, 2025 | -$1.41 | -$1.48 | -$1.80 - -$1.29 | +4.50% | Beat | N/A | 6 | 0 up, 4 down | May 12, 2025 |
| Dec 31, 2024 | -$1.62 | -$1.23 | -$1.36 - -$1.01 | -31.71% | Miss | N/A | 7 | 0 up, 1 down | Feb 27, 2025 |
| Sep 30, 2024 | -$1.24 | -$1.08 | -$1.15 - -$0.98 | -14.81% | Miss | N/A | 9 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.97 | -$1.12 | -$1.31 - -$0.94 | +13.39% | Beat | N/A | 9 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$1.03 | -$1.23 | -$1.43 - -$1.10 | +16.26% | Beat | N/A | 6 | 0 up, 0 down | May 14, 2024 |
| Dec 31, 2023 | -$1.50 | -$1.57 | -$1.70 - -$1.50 | +4.46% | Beat | N/A | 4 | 0 up, 0 down | Mar 4, 2024 |
| Sep 30, 2023 | -$1.63 | -$1.50 | -$1.70 - -$1.40 | -8.67% | Miss | N/A | 4 | 0 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$1.51 | -$1.47 | -$2.00 - -$1.20 | -2.72% | Miss | N/A | 5 | 0 up, 0 down | Aug 11, 2023 |
| Mar 31, 2023 | -$1.47 | -$1.50 | -$2.00 - -$1.30 | +2.00% | Beat | N/A | 5 | 0 up, 0 down | May 12, 2023 |
| Dec 31, 2022 | -$0.36 | -$0.36 | -$0.40 - -$0.34 | 0.00% | In line | N/A | 4 | 1 up, 0 down | Mar 8, 2023 |
| Sep 30, 2022 | -$3.20 | -$3.70 | -$3.70 - -$3.20 | +13.51% | Beat | N/A | 4 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$2.45 | -$3.60 | -$3.60 - -$2.30 | +31.94% | Beat | N/A | 3 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$3.54 | -$3.40 | -$3.60 - -$3.40 | -4.12% | Miss | -904.5% | 2 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.79 | -$0.34 | -$0.57 - -$0.24 | -132.35% | Miss | N/A | 4 | N/A | Mar 18, 2022 |
| Sep 30, 2021 | -$2.67 | -$2.70 | -$3.90 - -$1.70 | +1.11% | Beat | N/A | 4 | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$1.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | $0.44 | N/A | N/A | N/A | N/A | +300.0% | N/A | N/A | May 24, 2021 |
| Dec 31, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 |
| Sep 30, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2020 |
| Jun 30, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2020 |
| Mar 31, 2020 | $0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2020 |
| Dec 31, 2019 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 26, 2020 |
| Sep 30, 2019 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 20, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.82, after -$4.86 the year before. It was $0.00 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.82 | N/A |
| Dec 31, 2024 | -$4.86 | N/A |
| Dec 31, 2023 | -$6.11 | N/A |
| Dec 31, 2022 | -$9.55 | N/A |
| Dec 31, 2021 | -$4.33 | -7316.7% |
| Dec 31, 2020 | $0.06 | N/A |
| Dec 31, 2019 | $0.00 | N/A |
Frequently Asked Questions About JSPR
When is Jasper Therapeutics's next earnings date?
Jasper Therapeutics's next earnings report is expected for Mar 29, 2027.
Did JSPR beat earnings estimates last quarter?
No. Jasper Therapeutics reported EPS of -$33.93 for the quarter ended Sep 30, 2026, below the -$5.11 estimate by 563.99%.
What EPS do analysts expect from JSPR next quarter?
The consensus EPS estimate for Jasper Therapeutics for the quarter ending Dec 31, 2026 is -$9.08 from 7 analysts, with estimates from -$13.52 to -$2.84.
How often does JSPR beat earnings estimates?
Jasper Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -64.60%.
JSPR pages: Overview, Earnings, Forecast, Financials, Competitors